Brief: Kancera To Receive About SEK 18 Mln Through Redemption Of Warrants To4

Novakand Pharma AB

02/10/2020 09:57

Oct 2 (Reuters) - Kancera AB  KANC.ST :
    * TO RECEIVE ABOUT SEK 18 MILLION THROUGH REDEMPTION OF
WARRANTS
TO4
    * KANCERA AB SAYS THE PROCEEDS PROVIDE GOOD BASIS FOR
ACCELERATED
DEVELOPMENT OF CO'S DRUG PROJECTS AIMED AT COVID-19 AND
MYOCARDIAL INFARCTION, INCLUDING THE DRUG CANDIDATES KAND567 AND
KAND145
    * CANDIDATES KAND567 AND KAND145 ARE BEING DEVELOPED TO
PROTECT
VITAL ORGANS IN CONNECTION WITH HYPERINFLAMMATION THAT CAUSE
SERIOUS COMPLICATIONS IN, FOR EXAMPLE, ACUTE HEART DISEASE AND
VIRAL INFECTIONS
    * SECOND CLINICAL PHASE II STUDY OF KAND567 IS PLANNED TO
START IN
MYOCARDIAL INFARCTION PATIENTS DURING Q1 2021

Source text for Eikon:  ID:nWkrbnscXT 
Further company coverage:  KANC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))